Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2017-07-27
Original market date: See footnote 1
Product name:
MS CONTIN XL CAPSULES
DIN:
02242832 Electronic product monograph is not available
Company:
PURDUE PHARMA
310
3381 Steeles Avenue East
Toronto
Ontario
Canada
M2H 3S7
Class:
Human
Dosage form(s):
Capsule (Sustained-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
28:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N02AA01 MORPHINE
Active ingredient group (AIG) number:See footnote5
0104545013
Active ingredient(s) | Strength |
---|---|
MORPHINE SULFATE | 200 MG / SRC |